Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

NULL
   
  • Closing Price Chg:
      18.00p
  • 52 Week High: NULL
  • 52 Week Low: 233.00p
  • Currency: UK Pounds
  • Shares Issued: 106.14m
  • Volume: 0
  • RiskGrade: 125
  • Beta: 0.02

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
15-Jul-25 JP Morgan Cazenove Neutral 362.50p 490.00p 400.00p Reiteration
24-Sep-24 Deutsche Hold 377.00p 250.00p 380.00p Reiteration
21-May-24 RBC Capital Markets Outperform 331.50p - 740.00p Reiteration
20-Mar-24 Numis Hold 186.60p - 180.00p Reiteration
26-Sep-23 Liberum Capital Hold 291.50p 350.00p 310.00p Reiteration
19-Oct-21 Peel Hunt Limited Buy 1,512.00p 2,150.00p 2,150.00p Reiteration
13-Jul-17 Shore Capital Not Rated 8.85p - - Reiteration
06-Jul-17 N 1 Singer Hold 9.89p - 7.80p Reiteration
21-Oct-16 Jefferies Buy 3.16p - 8.00p Reiteration
18-Jun-14 Oriel Securities Add - - - Reiteration
10-Apr-14 Nplus1 Brewin Hold - 3.30p 3.30p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

OXB Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 18.00p
% Change 0.00 %
52 Week High NULL
52 Week Low 233.00p
Volume 0
Shares Issued 106.14m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.44% below the market average32.44% below the market average32.44% below the market average32.44% below the market average32.44% below the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Price Trend
53.87% above the market average53.87% above the market average53.87% above the market average53.87% above the market average53.87% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Income Not Available
Growth
4.65% above the market average4.65% above the market average4.65% above the market average4.65% above the market average4.65% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page